Unknown

Dataset Information

0

Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population.


ABSTRACT: Background:PPARG, PPARGC1A, and PPARGC1B polymorphisms may be implicated in the development of cancer. Participants and methods:In this study, we selected PPARG rs1801282 C>G and rs3856806 C>T, PPARGC1A rs2970847 C>T, and PPARGC1B rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk. A total of 584 HCC patients and 923 controls were enrolled. Results:We found that PPARG rs1801282 C>G polymorphism was correlated with a decreased susceptibility of HCC (CG vs CC, adjusted OR 0.47, 95% CI 0.27-0.82, P=0.007; CG/GG vs CC, adjusted OR 0.52, 95% CI 0.31-0.88, P=0.015). However, PPARG rs3856806 C>T polymorphism was a risk factor for HCC (TT vs CC, adjusted OR 2.33, 95% CI 1.25-4.36, P=0.008; TT vs CT/CC, adjusted OR 2.26, 95% CI 1.22-4.17, P=0.010). In a subgroup analysis by chronic hepatitis B virus (HBV)-infection status, age, sex, alcohol use, and smoking status, a significant association between PPARG rs1801282 C>G polymorphism and a decreased risk of HCC in male, ?53 years, never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups was found. However, we found PPARG rs3856806 C>T polymorphism increased the risk of HCC in never-smoking, never-drinking, and nonchronic HBV-infection-status subgroups. Haplotype-comparison analysis indicated that Crs1801282Trs3856806Crs2970847Grs7732671Grs17572019, Crs1801282Trs3856806Trs2970847Grs7732671Grs17572019, and Crs1801282Crs3856806Crs2970847Crs7732671Ars17572019 haplotypes increased the risk of HCC. PPARG Crs1801282Trs3856806 and Grs1801282Crs3856806 haplotypes also influenced the risk of HCC. Conclusion:In conclusion, our findings suggest PPARG polymorphisms may influence the susceptibility of HCC. The PPARG, PPARGC1A, and PPARGC1B haplotypes might be associated with HCC risk.

SUBMITTER: Zhang S 

PROVIDER: S-EPMC6087028 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relationship of <i>PPARG</i>, <i>PPARGC1A</i>, and <i>PPARGC1B</i> polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population.

Zhang Sheng S   Jiang Jiakai J   Chen Zhan Z   Wang Yafeng Y   Tang Weifeng W   Chen Yu Y   Liu Longgen L  

OncoTargets and therapy 20180808


<h4>Background</h4><i>PPARG</i>, <i>PPARGC1A</i>, and <i>PPARGC1B</i> polymorphisms may be implicated in the development of cancer.<h4>Participants and methods</h4>In this study, we selected <i>PPARG</i> rs1801282 C>G and rs3856806 C>T, <i>PPARGC1A</i> rs2970847 C>T, and <i>PPARGC1B</i> rs7732671 G>C and rs17572019 G>A single-nucleotide polymorphisms to explore the relationship between these polymorphisms and hepatocellular carcinoma (HCC) risk. A total of 584 HCC patients and 923 controls were  ...[more]

Similar Datasets

| S-EPMC5702164 | biostudies-literature
| S-EPMC5348366 | biostudies-literature
| S-EPMC5369979 | biostudies-literature
| S-EPMC5989317 | biostudies-literature
| S-EPMC6965258 | biostudies-literature
| S-EPMC6118282 | biostudies-literature
| S-EPMC6202459 | biostudies-literature
| S-EPMC5662339 | biostudies-literature
| S-EPMC5905468 | biostudies-literature
| S-EPMC3854376 | biostudies-literature